Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ALDH2_RAT
REST API REST API
Rattus norvegicus
ALDH2_RAT is differentially expressed in 78 experiments: 64 organism parts: hippocampus, frontal cortex, ... (62 more);, 5 disease states: normal, BDL 7 days, ... (3 more);, 9 cell types 1 cell lines 33 compound treatments and 15 other conditions.
Synonyms Q6Q290, Q6Q288, Q6Q289, Q8K3V8, Q91ZD7
Orthologs ENSCING00000021110 (Ciona intestinalis)   aldh2 (Xenopus tropicalis)   RP11-162P23.2.1 (Homo sapiens)   Aldh (Drosophila melanogaster)   ALDH2 (Homo sapiens)   E1BT93_CHICK (Gallus gallus)   Aldh2 (Mus musculus)   (Compare orthologs)
Gene Ontology Term oxidation-reduction process, response to hyperoxia, cellular response to hormone stimulus, liver development, cellular response to fatty acid, response to testosterone stimulus, response to progesterone stimulus, response to nicotine, mitochondrion, aldehyde dehydrogenase (NAD) activity, response to lipopolysaccharide, identical protein binding, mitochondrial matrix, metabolic process, oxidoreductase activity
InterPro Term Aldehyde dehydrogenase domain, Aldehyde dehydrogenase, conserved site, Aldehyde/histidinol dehydrogenase
UniProt Accession F1LN88, Q2QAI2, P11884
Search EB-eye ENSRNOG00000001344
Show more properties
Experimental Factors
organism part

studied in E-GEOD-19830, E-GEOD-2354, E-GEOD-20388, E-AFMX-7, E-GEOD-471, ... (20 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

cell line

studied in E-GEOD-4192

Factor Value U/D Experiments
SCN2.2
1
E-GEOD-4192


cell type

studied in E-MEXP-31, E-GEOD-830, E-GEOD-2499, E-TABM-130, E-TABM-432 ... (5 experiments)

Factor Value U/D Experiments
Sertoli cell
1
3
E-TABM-432, E-TABM-130, E-MEXP-31
total testis
1
E-MEXP-31
astrocyte
1
E-GEOD-2499
spermatogonium
1
1
E-TABM-432, E-MEXP-31
laminin binding germ cell
1
E-GEOD-830
neuron
1
E-GEOD-2499
3 more value(s).


disease state

studied in E-GEOD-1872, E-GEOD-464, E-MEXP-2583

Factor Value U/D Experiments
moderate spinal cord injury
2
1
E-GEOD-464
sham
1
E-MEXP-2583
normal
1
1
24
E-GEOD-1872, E-GEOD-464
breast carcinoma
1
E-GEOD-1872
BDL 7 days
1
E-MEXP-2583


Compound treatment

studied in E-GEOD-1872, E-MEXP-1169, E-GEOD-424, E-MTAB-797, E-GEOD-2303, ... (10 experiments)

Factor Value U/D Experiments
control
2
E-GEOD-4028, E-GEOD-1978
puromycin aminonucleoside 500 micromolar
1
E-MTAB-797
lornoxicam 3 micromolar
1
E-MTAB-797
butyrate 4.5 millimolar
1
E-GEOD-424
lornoxicam 0.6 micromolar
1
E-MTAB-797
carboplatin 600 micromolar
1
E-MTAB-797
27 more value(s).


age (months)

studied in E-GEOD-21681

Factor Value U/D Experiments
28
1
E-GEOD-21681
18
1
E-GEOD-21681


behavioral performance
studied in E-GEOD-21681

clinical treatment
studied in E-GEOD-738

day
studied in E-GEOD-20659

developmental stage
studied in E-GEOD-4236, E-GEOD-13793, E-MEXP-570, E-GEOD-903, E-GEOD-20245 ... (5 experiments)

genetic modification
studied in E-GEOD-6428

genotype
studied in E-GEOD-20214

growth condition
studied in E-GEOD-6102, E-GEOD-1567

material type
studied in E-GEOD-4192, E-MEXP-2527

phenotype
studied in E-GEOD-7041

protocol type
studied in E-MEXP-1565

replicate
studied in E-GEOD-4192

sampling time point
studied in E-MTAB-797

strain or line
studied in E-GEOD-7041, E-MTAB-322, E-TABM-457, E-GEOD-20388, E-GEOD-2116, ... (6 experiments)

treatment
studied in E-GEOD-7002, E-GEOD-691, E-GEOD-24672, E-GEOD-16981

Processing time: 1.338 secs.
 
Gene Expression Atlas 2.0.13- 4/23/12 11:55:46 AM